
Nordic heading for fourth exit of 2011

Final bids are due tomorrow for Swedish medical devices company Atos, currently owned by Nordic Capital.
It may mark the fourth exit this year for the GP: In April it sold its remaining shares in Falck; in May it sold Nycomed and just days after that it floated FinnvedenBulten.
The €9.6bn sale of Nycomed to Takeda was one of the largest M&A deals this year so far, trumping even SiverLake's sale of Skype to Microsoft. Nordic had initially acquired a stake in the pharma giant in a 1999 buyout, before selling it in an SBO to DLJ and Blackstone just three years later. Then in 2005 it re-invested in the business via a tertiary buyout.
Nordic acquired Atos in early 2005 from Fisher Scientific International Inc. At that time, the business posted revenues of SEK 260m and employed 180 staff. The business, under Nordic's stewardship, Atos has expanded aggressively through Europe. It entered the Iberian and Swiss markets and increased its presence in Germany through two add-on acquisitions in 2007. Further bolt-ons were made in 2008 (the Netherlands) and France last year. As a result of this growth, Atos now employs 290 people and posted revenues last year of EUR 64m, nearly 3x those when Nordic acquired its controlling stake.
Despite private equity's penchant for replacing management, Atos' CEO Tommy Hedberg has remained at the helm since before Nordic's involvement.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater